[Federal Register Volume 86, Number 48 (Monday, March 15, 2021)]
[Notices]
[Pages 14327-14328]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-05218]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Lead Exposure and Prevention Advisory Committee (LEPAC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Lead Exposure and Prevention 
Advisory Committee (LEPAC). This meeting is open to the public by 
teleconference but advance registration by April 30, 2021, is needed to 
receive the information to join the meeting. The registration link is 
https://rossstrategic.zoom.us/webinar/register/WN_1vfWQt1_TdSOj1Laoo8bIw.

DATES: The meeting will be held on May 14, 2021, from 9:00 a.m. to 4:30 
p.m., EDT.

ADDRESSES: Register in advance at https://rossstrategic.zoom.us/webinar/register/WN_1vfWQt1_TdSOj1Laoo8bIw to receive information to 
join the meeting.

FOR FURTHER INFORMATION CONTACT: Ms. Perri Ruckart, Dr. P.H. 
(candidate), M.P.H., Designated Federal Officer, National Center for 
Environmental Health, CDC, 4770 Buford Highway, Atlanta, GA 30341, 
Telephone: (770) 488-3300; [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Lead Exposure and Prevention Advisory Committee was 
established under Section 2203 of Public Law 114-322, the Water

[[Page 14328]]

Infrastructure Improvements for the Nation Act; 42 U.S.C. 300j-27, 
Registry for Lead Exposure and Advisory Committee. The Secretary, 
Department of Health and Human Services (HHS) and by delegation, the 
Director, CDC and Administrator, NCEH/ATSDR, are authorized under 
Section 2203 of Public Law 114-322 (42 U.S.C. 300j-27) to review 
research and Federal programs and services related to lead poisoning 
and to identify effective services and best practices for addressing 
and preventing lead exposure in communities.
    The LEPAC is charged with providing advice and guidance to the 
Secretary, HHS, and the Director, CDC and Administrator, ATSDR, on (1) 
reviewing Federal programs and services available to individual 
communities exposed to lead; (2) reviewing current research on lead 
exposure to identify additional research needs; (3) reviewing and 
identifying best practices, or the need for best practices regarding 
lead screening and the prevention of lead poisoning; (4) identifying 
effective services, including services relating to healthcare, 
education, and nutrition for individuals and communities affected by 
lead exposure and lead poisoning, including in consultation with, as 
appropriate, the lead exposure registry as established in Section 2203 
(b) of Public Law 114-322; and (5) undertaking any other review or 
activities that the Secretary determines to be appropriate.
    Matters To Be Considered: The agenda will include discussions on 
the Federal Lead Action Plan, American Healthy Homes Survey II, a 40-
Year National Health and Nutritional Examination Survey (NHANES) 
Analysis of lead data, the Blood Lead Reference Value (BLRV) Workgroup, 
and the 2020 Annual LEPAC Report. Agenda items are subject to change as 
priorities dictate.

Public Participation

    Procedure for Oral Public Comment: The public comment period is 
scheduled on May 14, 2021, from 11:45 a.m. until 12:00 p.m. Individuals 
wishing to make a comment during the public comment period, please 
email your name, organization, and phone number by April 30, 2021, to 
[email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-05218 Filed 3-12-21; 8:45 am]
BILLING CODE 4163-18-P